Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Phillips-Medisize and InterSystems teamed up for Connected Health Platform

precision-medicine
Phillips-Medisize (USA), a Molex company, has joined forces with InterSystems, a global leader in healthcare software technology to develop the third-generation Connected Health Platform. Philips ...

Novo Nordisk sets up a GMP manufacturing facility in USA

novo nordisk
Novo Nordisk announced the establishment of a manufacturing site in Fremont, California (USA) to develop and produce stem cell-based therapies.

WuXi AppTec launches a new DNA technology to gear up drug discovery

dna
WuXi AppTec (China), a leading pharmaceutical and medical device technology platform company, launched a new DNA-Encoded Library (DEL) Construction & Screening Platform

Heidelberg Pharma and Magenta Therapeutics prolongate a research cooperation

drug development
Heidelberg Pharma announced that its partner Magenta Therapeutics exercises its option to further continue the development of an Antibody Targeted Amanitin Conjugate.

Aptar Pharma launches a new drug development support kit

lab equipment
Aptar Pharma in combination with Schott Glass and EMA Pharmaceuticals, announced the launch of Aptar Pharma QuickStart™ for injectable drug development.

Korean scientists unveiled biosensor for optimizing microbial cell factories

stem-cell
A research group at Korea Advanced Institute of Science and Technology (KAIST) presented a novel biosensor which can produce diverse, high-level microbial cell factories.

Scientists developed new tool for open exchange of biomaterials

test-tubes
A new easy-to-use legal tool that enables open exchange of biological materials was launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in...

Themis Bioscience signs licensing agreement with Max-Planck-Innovation

research
Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany.

BioDuro created new drug discovery center for chemistry and biology

drug discovery
BioDuro, a leading global life sciences contract research and development organization announced that it has established a new drug discovery center for chemistry and biology in San Diego (USA).

Pfizer rewards $3 million in grants for breast cancer researchers

lab research
Pfizer announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast Cancer Research Awards.

Researchers unveiled the first bio-electronic medicine

digital drug
Researchers at Northwestern University and Washington University School of Medicine have developed the first example of a bioresorbable electronic medicine.

Merck KGaA starts M Lab Collaboration Center in Brazil

merck kgaa
The center will provide Life Science customers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers.

TriNetX presented new analytical tools for self-service precision medicine

precision-medicine
TriNetX (USA) showcased a series of new analytical tools that enable more people to conduct health research on their own.

PharmaBlock Sciences acquires a GMP manufacturing facility in China

pharma
PharmaBlock Sciences, an innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced that it has acquired a GMP compliant manufacturing facility in China.

Celltrion enters into an ‘incubation’ agreement with Emory University

celltrion
Celltrion (South Korea) signed an ‘Incubation’ agreement with Emory University (Atlanta, USA) to support the research and development of new drug candidates for atherosclerosis.

Sulk Institute scientists reported a novel gene-editing tool

molecules
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions , announced a commercial supply agreement with Aucta Pharmaceuticals.